nafagrel has been researched along with Blood Pressure, High in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Ashida, S; Irie, K; Kunitada, S; Masumura, H | 1 |
1 other study(ies) available for nafagrel and Blood Pressure, High
| Article | Year |
|---|---|
A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy.
Topics: Acetylglucosaminidase; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; gamma-Glutamyltransferase; Heart Rate; Hypertension; Imidazoles; Kidney; Prostaglandins; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase | 1992 |